Specialist · Cardiology
Prof. Dr. Gerasimos Siasos
Specialist for Cardiology in Athens
Nationalen und Kapodistrias-Universität Athen· Panepistimiou 30, 10679 Athens

cardiovascular disease, particularly atherosclerosis, arterial stiffness and preventive cardiology. His research focuses on biomarkers for risk assessment, antithrombotic therapies and the impact of metabolic diseases such as diabetes on the heart. As Professor and Clinical Director, he combines medical practice, innovative research and teaching at the National and Kapodistrias University of Athens.
Areas of focus
Cardiovascular diseases
- Coronary heart disease (CHD)
- Atherosclerosis and endothelial dysfunction
- Arterial stiffness as a risk factor for cardiovascular events
Preventive cardiology
- Early detection and risk assessment of cardiovascular diseases
- Significance of inflammatory markers for the prognosis of patients
- Influence of metabolic diseases such as diabetes on the heart
Interventional cardiology
- Percutaneous coronary interventions (stent implantations)
- Antithrombotic therapies and coagulation management
- Optimization of treatment after cardiovascular interventions
Molecular cardiology and research
- Investigation of biomarkers for risk stratification
- Role of osteoprotegerin (OPG) in vascular diseases
- Effects of blood lipids and oxidative stress on the heart
About Prof. Dr. Gerasimos Siasos
Professor Gerasimos Siasos has extensive medical expertise in the field of cardiology, particularly in the research and treatment of cardiovascular diseases. One focus of his research is the investigation of arterial stiffness and its prognostic significance in patients with stable coronary heart disease. In a study of 262 patients who had undergone percutaneous coronary intervention, he found that increased arterial stiffness, as measured by carotid-femoral pulse wave velocity (PWV), was associated with an increased risk of serious cardiovascular events. Specifically, the study showed that for every 1 m/s increase in PWV, the risk of such events increases by 29%. These findings underline the importance of PWV measurement as a potential marker for the prognosis and management of patients with stable coronary artery disease.
Another area of Professor Siasos' research concerns the role of osteoprotegerin (OPG) as a biomarker for arterial stiffness. In a study of 115 hypertensive patients, he found that elevated serum OPG levels correlate positively with the Cardio-Ankle Vascular Index (CAVI), a measure of arterial stiffness. This suggests that OPG may serve as an independent predictor of arterial stiffness in hypertensive patients.
Professor Siasos has also investigated the importance of antithrombotic therapies in patients with coronary heart disease. He emphasizes the challenge of finding the balance between the prevention of thrombotic events and the risk of bleeding complications. His work helps to determine the optimal treatment strategy for patients with cardiovascular disease.
Location
How to reach Prof. Dr. Gerasimos Siasos
Nationalen und Kapodistrias-Universität Athen
Specialisation
The medical spectrum of Prof. Dr. Gerasimos Siasos
Diseases
- Congenital Heart Defects (opens in a new tab)
- Atrial Septal Defect (opens in a new tab)
- Angina pectoris (opens in a new tab)
- Aortic valve stenosis (opens in a new tab)
- High Blood Pressure (opens in a new tab)
- Heart Attack (opens in a new tab)
- Heart Failure (opens in a new tab)
- Heart Disease (opens in a new tab)
- Myocarditis (opens in a new tab)
- Heart palpitations (opens in a new tab)
- Cardiomyopathy (opens in a new tab)
- Coronary Heart Disease (opens in a new tab)
- Pericardial effusion (opens in a new tab)
- Atrial Fibrillation (opens in a new tab)
- Dyspnea (opens in a new tab)
- Heart Rhythm Disorders (opens in a new tab)
- Fainting (Syncope) (opens in a new tab)
- Metabolic Syndrome (opens in a new tab)
- Heart defect (opens in a new tab)
- HOCM (Hypertrophic Obstructive Cardiomyopathy) (opens in a new tab)
Treatments
- Balloon Catheter Angioplasty (PTCA) (opens in a new tab)
- Cardiac Resynchronization Therapy (CRT) (opens in a new tab)
- Stent Implantation (opens in a new tab)
- PTCA (opens in a new tab)
- Cardioversion (opens in a new tab)
- Catheter Ablation (opens in a new tab)
- TASH Treatment (opens in a new tab)
- Anticoagulation (opens in a new tab)
- Device Therapy (opens in a new tab)
- Electrophysiology (opens in a new tab)

